TI
GNMK

Turner Investments’s GenMark Diagnostics, Inc GNMK Stock Holding History

Turner Investments’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-65,000
Closed -$767K – 303
2016
Q3 		$767K Buy
65,000
+40,000
+160% +$386K 0.25% 125
2016
Q2 		$218K Buy
+25,000
New +$171K 0.07% 180

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Turner Investments's GNMK Position: Q4 2016 in Review

Turner Investments sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2016, closing a stake of 65,000 shares — an estimated $767K sold.

Turner Investments first reported a position in GNMK in Q2 2016 and held it in 2 quarters. The position peaked at $767K in Q3 2016. 90 funds tracked by Wall St. Rank hold GNMK as of Q4 2016.

  • Turner Investments reported no remaining GenMark Diagnostics, Inc position as of Q4 2016 after selling out during the quarter.
  • Turner Investments sold 65,000 GenMark Diagnostics, Inc shares in Q4 2016, an estimated $767K.
  • Turner Investments first reported a position in GenMark Diagnostics, Inc in Q2 2016 and held it in 2 quarters.
  • Turner Investments's GenMark Diagnostics, Inc position peaked at $767K in Q3 2016.
  • 90 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2016.

Based on Turner Investments's 13F filing for Q4 2016, filed 8 Feb 2017.